(Q37710849)

22 August 2017

1 reference

title

Corticotropin-releasing hormone, glutamate, and γ-aminobutyric acid in depression (English)

1 reference

22 August 2017

Shang-Feng Gao

1

1 reference

PubMed ID

20236945

22 August 2017

Ai-Min Bao

series ordinal

2

1 reference

PubMed ID

20236945

22 August 2017

language of work or name

1 reference

16 March 2010

1 reference

22 August 2017

1 reference

22 August 2017

17

1 reference

22 August 2017

1

1 reference

22 August 2017

124-144

1 reference

Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression

22 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Plasma and platelet excitatory amino acids in psychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Elevated CSF CRF in suicide victims

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Gamma-aminobutyric acid-B (GABAB) binding sites in postmortem suicide brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Increased corticotropin-releasing hormone immunoreactivity in monoamine-containing pontine nuclei of depressed suicide men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Cerebrospinal fluid neuropeptides in mood disorder and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Colocalization of corticotropin-releasing hormone and oestrogen receptor-alpha in the paraventricular nucleus of the hypothalamus in mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

The stress system in depression and neurodegeneration: focus on the human hypothalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

An open label trial of C-1073 (mifepristone) for psychotic major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Glutamate decarboxylase(65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Antidepressant effects of ketamine in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Platelet GABA-transaminase in affective illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Low GABA concentrations in occipital cortex and anterior cingulate cortex in medication-free, recovered depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Dysregulation of GABAergic neurotransmission in mood disorders: a postmortem study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Elevated concentrations of CRF in the locus coeruleus of depressed subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Plasma GABA levels correlate with aggressiveness in relatives of patients with unipolar depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

GABA transporter heterogeneity: pharmacology and cellular localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

A different depression: clinical distinctions between bipolar and unipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Hypothalamic integration of central and peripheral clocks

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Regulation of neurotransmitter release by metabotropic glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Plasma corticotropin-releasing factor in depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

A glutamatergic model of ECT-induced memory dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

GABAC receptor ion channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

The 'ABC' of GABA receptors: a brief review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Serotonin and depression: pathophysiological mechanism or marketing myth?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Brain GABAB binding sites in depressed suicide victims

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Don't worry 'B' happy!: a role for GABA(B) receptors in anxiety and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Glucocorticoid signaling and stress-related limbic susceptibility pathway: about receptors, transcription machinery and microRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Stress and the brain: from adaptation to disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Effects of the selective nonpeptide corticotropin-releasing factor receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Metabolism and role of glutamate in mammalian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Two genes encode distinct glutamate decarboxylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and Reelin proteins in cerebellum

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

CSF corticotropin-releasing factor-like immunoactivity in chronic pain patients with and without major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Low cerebrospinal fluid glutamate and glycine in refractory affective disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Plasma corticotropin-releasing factor in depressed patients before and after the dexamethasone suppression test

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Corticotropin-releasing factor: a marked circadian rhythm in primate cerebrospinal fluid peaks in the evening and is inversely related to the cortisol circadian rhythm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Low cerebrospinal fluid corticotropin-releasing hormone concentrations in eucortisolemic depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

CSF neurochemistry of women with anorexia nervosa and normal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Concentration gradients of free and total gamma-aminobutyric acid and homocarnosine in human CSF: comparison of suboccipital and lumbar sampling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Role of GABA and glutamate circuitry in hypothalamo-pituitary-adrenocortical stress integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Localization of VGLUT3, the vesicular glutamate transporter type 3, in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Bipolar mania and plasma amino acids: increased levels of glycine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

NMDA glutamatergic receptors, labelled with [3H]MK-801, in brain samples from drug-free depressed suicides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Central CRH system in depression and anxiety--evidence from clinical studies with CRH1 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Clinical and experimental studies on the role of GABA in the regulation of ACTH secretion: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

A diurnal rhythm in cerebrospinal fluid corticotrophin-releasing hormone different from the rhythm of pituitary-adrenal activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Elevated levels of the NR2C subunit of the NMDA receptor in the locus coeruleus in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Corticotropin-releasing hormone in depression and post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Cerebrospinal Fluid Immunoreactive Cortieotropin-Releasing Hormone and Adrenocorticotropin Secretion in Cushing's Disease and Major Depression: Potential Clinical Implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

GABA(A) receptor subtypes as targets for neuropsychiatric drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Small-dose ketamine improves the postoperative state of depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Psychopathology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Stress-restress: effects on ACTH and fast feedback.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Reduced anxiety and depression-like behaviors in mice lacking GABA transporter subtype 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: modulation by treatment with antidepressants and prediction of clinical responsivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Glutamate: its role in learning, memory, and the aging brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Corticotropin-releasing hormone, arginine vasopressin, gastrin-releasing peptide, and neuromedin B alterations in stress-relevant brain regions of suicides and control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Neurotrophic effects of electroconvulsive therapy: a proton magnetic resonance study of the left amygdalar region in patients with treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Neuroscience. The dark side of glia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Reduced anterior cingulate cortex glutamatergic concentrations in childhood major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

CSF somatostatin in Alzheimer's disease and major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Selective cortical VGLUT1 increase as a marker for antidepressant activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Evidence-Based Health Policy---Lessons from the Global Burden of Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Reduced glucocorticoid receptors: consequence or cause of depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Neurobiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Neuropeptide Y and corticotropin-releasing hormone in CSF mark response to antidepressive treatment with citalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

CSF monoamine metabolites and neuropeptides in depressed patients before and after electroconvulsive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Glial reduction in the subgenual prefrontal cortex in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Antidepressant-like effects of CRF1 receptor antagonist SSR125543 in an animal model of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Changes in plasma amino acids after electroconvulsive therapy of depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Benzodiazepine receptors in the post-mortem brain of suicide victims and schizophrenic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

GABA and behavior: the role of receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

The glucocorticoid receptor: part of the solution or part of the problem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

The HPA axis in major depression: classical theories and new developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

GABA and glutamate in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

GABA and mood disorders: a brief review and hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Evidence for the segregation of a major gene for human plasma GABA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Low plasma GABA is a trait-like marker for bipolar illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Low plasma gamma-aminobutyric acid levels in male patients with depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Plasma GABA levels in psychiatric illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Reduced anterior cingulate glutamate in pediatric major depression: a magnetic resonance spectroscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Effect of acute and chronic benzodiazepines on plasma GABA in anxious patients and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

CSF corticotropin-releasing hormone in depressed patients and normal control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

GABAergic contributions to the pathophysiology of depression and the mechanism of antidepressant action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Decreased hippocampal NMDA, but not kainate or AMPA receptors in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications for the pathophysiology of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Excitatory amino acid transporters: a family in flux

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Molecular pharmacology of glutamate transporters, EAATs and VGLUTs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Benzodiazepine binding sites in amygdala and hippocampus of depressed suicide victims

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Amantadine as augmentation therapy in the management of treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

[(3)H]Tiagabine binding to GABA transporter-1 (GAT-1) in suicidal depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

GABA uptake sites in frontal cortex from suicide victims and in aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

The stress system in the human brain in depression and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Interaction of prefrontal cortical and hypothalamic systems in the pathogenesis of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Differential effects of citalopram and reboxetine on cortical Glx measured with proton MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Evidence for increased expression of the vesicular glutamate transporter, VGLUT1, by a course of antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

NMDA receptor subunit NRI and postsynaptic protein PSD-95 in hippocampus and orbitofrontal cortex in schizophrenia and mood disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Glial fibrillary acidic protein and glutamine synthetase in subregions of prefrontal cortex in schizophrenia and mood disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Effect of desipramine on cerebrospinal fluid concentrations of corticotropin-releasing factor in human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Treatment of depression with antiglucocorticoid drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

An open-label trial of riluzole in patients with treatment-resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Alterations in arginine vasopressin neurons in the suprachiasmatic nucleus in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Normal [3H]flunitrazepam binding to GABAA receptors in the locus coeruleus in major depression and suicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Preliminary studies on CSF gamma-aminobutyric acid levels in psychiatric patients before and during treatment with different psychotropic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858410361780

21 January 2018

Identifiers

DOI

10.1177/1073858410361780

1 reference

22 August 2017

1 reference

PubMed ID

20236945